Recent accounting scandals have left a sour taste in investors' mouths, limiting their willingness to deal with anything that even hints at potential shenanigans. Today, Accretive Health (NYSE: AH) shares were slammed after announcing a delay in reporting its quarterly financial results and withdrawing its prior guidance. Was the announcement worthy such a harsh reaction, or is there a good reason behind the delay? Follow along in the video below as Brenton Flynn runs through the news.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.